Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Korro Bio, Inc.'s ticker is KRRO.
The company's shares trade on the NASDAQ stock exchange.
They are based in Cambridge, MA.
There are 112 employees working at Korro Bio, Inc..
It is korrobio.com.
Korro Bio, Inc. is in the Healthcare sector.
Korro Bio, Inc. is in the Biotechnology industry.
The following companies are Korro Bio, Inc.'s peers in the Biotechnology industry:
Create a free account to access this section for Korro Bio, Inc. and every other company in our database.